Abstract 4CPS-122 Table 1
Chemotherapy regimens
All patients
Doublets-T
Triplets-T
Others-T
N (%)
255 (100%)
214 (85%)
13 (5%)
26 (10%)
OS, months (CI 95%)
14.3 (11–22)
14.7 (12–17)
12.7 (9–44)
82 (5–20)
PFS, months (CI 95%)
8.1 (7–9)
8.5 (8–10)
8 (6–16)
5.2 (3–7)